NCT02009189

Taurolidine Lock in Long Term Parenteral Nutrition

The Value of Taurolidine Lock in Long Term Parenteral Nutrition

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: Stanley Dudrick's Memorial Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Taurolidine alone or in combination with citrate have been proposed for locking the catheter to reduce the number of catheter infections. As there is not enough evidence to give recommendations in this regard, the study tested the hipothesis that taurolidine improves the outcome of long term paretneral nutrition.

Conditions

• Home Parenteral Nutrition
• Central Venous Catheter

Interventions

Type	Name	Description
DRUG	2% Taurolidine Lock	Catheter lock with 2% Taurolidine
DRUG	1.35% Taurolidine	Catheter lock with 1.35% Taurolidine + citrate

Timeline

• Start date: 2012-11-01
• Primary completion: 2013-11-01
• Completion: 2013-12-01
• First posted: 2013-12-11
• Last updated: 2013-12-11

Locations

1 site across 1 country: Poland